Latest Breaking News On - தொராசி புற்றுநோயியல் - Page 4 : vimarsana.com

MET amplification identified as a potentially actionable driver for non-small cell lung cancer A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC). Camidge says many of the major developments in the treatment of non-small cell lung cancer have come from defining molecularly specific subsets of the disease for which researchers have been able to develop targeted treatments. Until now, all of these subsets have been based on either genetic mutations or gene rearrangements (where two separate genes fuse to create an oncogene).

United statesMarileila varella garciaD ross camidgeEmily hendersonSchool of medicineUniversity of colorado school medicineCu cancer centerColorado schoolPatients withThoracic oncologyRoss camidgeஒன்றுபட்டது மாநிலங்களில்எமிலி ஹென்டர்சன்பள்ளி ஆஃப் மருந்துபல்கலைக்கழகம் ஆஃப் கொலராடோ பள்ளி மருந்துசு புற்றுநோய் மையம்